info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Gastroparesis Treatment Market Research Report Information, by Gastroparesis Type (Idiopathic, Diabetic, Post-surgical and Others), by Drug Class (Prokinetic drugs, Antiemetics, Antidepressants and Others) and by Other Treatment (Jejunostomy, Gastric electric stimulation (GES) and Parenteral Nutrition) - Forecast till 2032


ID: MRFR/Pharma/2322-HCR | 84 Pages | Author: Rahul Gotadki| October 2024

Global Gastroparesis Treatment Market Overview


The Gastroparesis Treatment Market is anticipated to reach USD 8.27 Billion by 2032 at 3.2% CAGR during the forecast period 2023-2032.Gastroparesis is a condition of delayed gastric emptying because of partial paralysis of the stomach, resulting in food remaining in the stomach for an abnormally long time.


Gastroparesis Treatment Market


Latest Industry Developments in Gastroparesis Treatment Market

June 2024
,Medtronic has introduced a new gastrostomy tube with advanced sensor technology, enabling real-time monitoring of gastric motility and pressure, aiding in better management of gastroparesis symptoms.

May 2024,Abbott has introduced an upgraded gastric electrical stimulation device, featuring improved algorithms for personalized stimulation settings, aimed at improving gastric motility in gastroparesis patients through more precise and adaptive electrical impulses.

The gastric muscles contracts to move food down into the small intestine which is controlled by the vagus nerve. Damage to the vagus nerve or the muscles of the stomach and intestines causes food to move slowly resulting in Gastroparesis. Gastroparesis predominantly affects young adult females. Although Gastroparesis is frequently associated with diabetes, idiopathic Gastroparesis accounts for the greatest number of cases.


The other market driving factors of Gastroparesis are surgery on the stomach or vagus nerve, anorexia nervosa, use of narcotics that slow gastric contractions, gastroesophageal reflux disease, disorders, such as amyloidosis and scleroderma, Parkinson's disease, metabolic disorders such as hypothyroidism, etc.


Study Objectives Gastroparesis Treatment Market:



  • To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the global Gastroparesis Treatment market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, Porters Five Force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by Gastroparesis type, by drug class, by other treatment and other sub segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.


Global Gastroparesis Treatment Market Share, by Gastroparesis Type, 2016 (%):

 


Gastroparesis Treatment Market Share 




Gastroparesis Treatment Segment Insights


Global Gastroparesis Treatment market has been segmented on the basis of Gastroparesis type which comprises idiopathic, diabetic, post-surgical and others. 


Gastroparesis Treatment Drug Class Insights


On the basis of drug class the market comprises of prokinetic drugs, antiemetics, antidepressants and others. 


Gastroparesis Treatment Insights


On the basis of other treatment; market is segmented into jejunostomy, gastric electric stimulation (GES) and parenteral nutrition.


Gastroparesis Treatment Regional Insights


Globally America is the largest market for Gastroparesis treatment. Europe is the second-largest market for Gastroparesis Treatment. Reasons for dominance of the developed regions is the faster market uptake, higher per capita income and excellent reimbursement scenario in these regions. Asia Pacific region is expected to be witness fastest growth and most of it will be led by Japan, China and India.


Key Players for Global Gastroparesis Treatment Market:



  • Medtronic

  • Kimberly-Clark Corporation

  • Abbott Laboratories

  • Salix Pharmaceuticals, Inc

  • Boston Scientific Corporation

  • C. R. Bard, Inc

  • Janssen Global Services

  • LLC

  • Cardinal Health, Inc.

  • Alfa Wassermann SPA

  • Evoke Pharma

  • Rhythm Pharmaceuticals, Inc


Intended Audience



  • Gastroparesis Treatment manufacturers

  • Gastroparesis Treatment suppliers

  • Private research laboratories

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Government research laboratories


The report for global Gastroparesis Treatment market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 8.27 Billion
  CAGR   3.2%
  Base Year   2021
  Forecast Period   2023-2032
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Gastroparesis Type, Drug Class, Other Treatment
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Medtronic, Kimberly-Clark Corporation, Abbott Laboratories, Salix Pharmaceuticals, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Janssen Global Services, LLC, Cardinal Health, Inc., Alfa Wassermann SPA, Evoke Pharma, Rhythm Pharmaceuticals
  Key Market Opportunities ·  Higher Per Capita Income·  Excellent Reimbursement Scenario in America Regions
  Key Market Drivers   Rising number of cases among adult females and use of drugs for slowing gastic contractions


Frequently Asked Questions (FAQ) :

Gastroparesis treatment market is expected to touch a value of USD 8.27 Billion by 2032.

Gastroparesis treatment market can showcase a CAGR of 3.2% from 2023-2032.

Gastroparesis treatment market is driven by the rising number of cases among adult females and use of drugs for slowing gastic contractions.

Lack of awareness among farmers can hamper the growth of the global gastroparesis treatment market.

Rhythm Pharmaceuticals, Inc., Janssen Global Services, Abbott Laboratories, Boston Scientific Corporation, C. R. Bard, Inc., LLC, Cardinal Health, Inc., Salix Pharmaceuticals, Inc., Alfa Wassermann SPA, Kimberly-Clark Corporation, Medtronic, Evoke Pharma, and others are notable players of the global gastroparesis treatment market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.